作者
Valeriya Lyssenko, Roberto Lupi, Piero Marchetti, Silvia Del Guerra, Marju Orho-Melander, Peter Almgren, Marketa Sjögren, Charlotte Ling, Karl-Fredrik Eriksson, Rita Mancarella, Göran Berglund, Tiinamaija Tuomi, Peter Nilsson, Stefano Del Prato, Leif Groop
发表日期
2007/8/1
期刊
The Journal of clinical investigation
卷号
117
期号
8
页码范围
2155-2163
出版商
American Society for Clinical Investigation
简介
Transcription factor-7–like 2 (TCF7L2) is the most important type 2 diabetes susceptibility gene identified to date, with common intronic variants strongly associated with diabetes in all major racial groups. This ubiquitous transcription factor in the Wnt signaling pathway was not previously known to be involved in glucose homeostasis, so defining the underlying mechanism (s) will provide new insights into diabetes. In this issue of the JCI, Lyssenko and colleagues report on their human and isolated islet studies and suggest that the risk allele increases TCF7L2 expression in the pancreatic β cell, reducing insulin secretion and hence predisposing the individual to diabetes (see the related article beginning on page 2155).
引用总数
200720082009201020112012201320142015201620172018201920202021202220232024117275807787727274667261574953393224
学术搜索中的文章
V Lyssenko, R Lupi, P Marchetti, S Del Guerra… - The Journal of clinical investigation, 2007